Search
Patexia Research
Case number 2021-1154

Celgene Corporation v. Mylan Pharmaceuticals Inc. > Documents

Date Field Doc. No.Description (Pages)
Dec 23, 2021 0 CELGENE CORPORATION v. MYLAN PHARMACEUTICALS INC. [OPINION] [precedential] (0)
Dec 13, 2021 52 Mandate issued to the United States District Court for the District of New Jersey. Service as of this date by the Clerk of Court. [818019] [MVH] [Entered: 12/13/2021 10:50 AM] (1)
Nov 5, 2021 51 JUDGMENT. AFFIRMED. Terminated on the merits after oral argument. COSTS: Costs taxed against Appellant(s). Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. Service as of this date by the Clerk of Court. [810427] [MVH] [Entered: 11/05/2021 10:04 AM] (1)
Nov 5, 2021 50 OPINION filed for the court by Prost, Circuit Judge; Chen, Circuit Judge and Hughes, Circuit Judge. Precedential Opinion. Service as of this date by the Clerk of Court. [810426] [MVH] [Entered: 11/05/2021 10:04 AM] (29)
Nov 3, 2021 49 RESPONSE of Appellees Mylan Inc., Mylan N.V. and Mylan Pharmaceuticals Inc. to Doc. No. [48]. Service: 11/03/2021 by email. [810101] [21-1154] [Tung Kong] [Entered: 11/03/2021 05:36 PM] (1)
Oct 27, 2021 48 Clerk's SEALED letter to the parties regarding confidentiality waiver. Response due on or before 11/03/2021. Service as of this date by the Clerk of Court. [808586] [MJL] [Entered: 10/27/2021 04:08 PM] (0)
Sep 2, 2021 47 Submitted after ORAL ARGUMENT to Panel: Prost, Circuit Judge; Chen, Circuit Judge and Hughes, Circuit Judge.Arguing counsel: Ms. Ellyde R. Thompson for Celgene Corporation and Mr. Tung On Kong for Mylan Pharmaceuticals Inc., Mylan Inc. and Mylan N.V.Oral Argument Audio available here. [796927] [JCP] [Entered: 09/02/2021 02:19 PM] (0)
Aug 16, 2021 46 Response to notice of oral argument from Appellees Mylan Inc., Mylan N.V. and Mylan Pharmaceuticals Inc.. Service: 08/16/2021 by email. [792981] [21-1154] [Tung Kong] [Entered: 08/16/2021 04:30 PM] (3)
Aug 12, 2021 45 Form 33A Certification Of Compliance With Revised Protocols For In-Person Argument for Appellant Celgene Corporation. Service: 08/12/2021 by email. [792284] [21-1154] [Ellyde Thompson] [Entered: 08/12/2021 02:11 PM] (2)
Aug 12, 2021 44 Counsel are advised that the Federal Circuit has issued Revised Protocols for In-Person Arguments. All arguing counsel, including counsel who have already filed a Response to Notice of Oral Argument, must file revised Form 33A no later than 08/16/2021. Form 33A may be attached to the Response to Notice of Oral Argument or filed as Other Document. [792219] [MJL] [Entered: 08/12/2021 10:58 AM] (0)
Aug 11, 2021 43 Response to notice of oral argument from Appellant Celgene Corporation. Service: 08/11/2021 by email. [792111] [21-1154] [Ellyde Thompson] [Entered: 08/11/2021 05:35 PM] (1)
Jul 21, 2021 42 NOTICE OF ORAL ARGUMENT. Panel: 2109H. Case scheduled September 2, 2021. Response to Notice of Oral Argument due: 08/16/2021. Please review the attached Notice. The response to notice of oral argument form can be found here. The Oral Argument Guide can be found here. Service as of this date by the Clerk of Court. [787809] [MVH] [Entered: 07/21/2021 05:03 PM] (2)
May 17, 2021 41 6 paper copies of Doc. No. [22] received from Appellees Mylan Inc. and Mylan Pharmaceuticals Inc.. [775946] [VDW] [Entered: 05/19/2021 11:07 AM] (0)
May 12, 2021 40 The following conflict dates submitted by Tung On Kong for Mylan Pharmaceuticals Inc., Mylan Inc. and Mylan N.V. have been accepted by the court: 07/06/2021, 07/07/2021, 07/08/2021, 07/09/2021, 08/02/2021, 08/03/2021, 08/04/2021, 08/05/2021, 08/06/2021. [774519] [MJL] [Entered: 05/12/2021 11:54 AM] (0)
May 11, 2021 38 Notice from Appellant Celgene Corporation regarding conflicts with oral argument. None. Service: 05/11/2021 by email. [774398] [21-1154] [Ellyde Thompson] [Entered: 05/11/2021 07:35 PM] (0)
May 11, 2021 37 Notice from Appellees Mylan Inc., Mylan N.V. and Mylan Pharmaceuticals Inc. regarding conflicts with oral argument. Service: 05/11/2021 by email. [774369] [21-1154] [Tung Kong] [Entered: 05/11/2021 04:36 PM] (2)
May 7, 2021 39 6 paper copies of Doc. No. [30], [27], [18] received from Appellant Celgene Corporation. [774491] [VDW] [Entered: 05/12/2021 11:24 AM] (0)
May 4, 2021 36 Notice to counsel: The Clerk's Office directs that outstanding paper copies of all briefs and appendices in this case must be submitted on or before May 11, 2021. See Administrative Order No. 20-01 (Mar. 20, 2020). [772794] [KMH] [Entered: 05/04/2021 01:24 PM] (0)
May 4, 2021 35 Notice to Advise of Scheduling Conflicts. Arguing counsel must advise of, and show good cause for, any scheduling conflicts during the upcoming court session months listed in the attached notice. The Response to Notice to Advise of Scheduling Conflicts can be found here. The Oral Argument Guide can be found here. [772793] [KMH] [Entered: 05/04/2021 01:19 PM] (1)
Apr 30, 2021 34 MODIFIED ENTRY: CORRECTED REPLY BRIEF FILED by Appellant Celgene Corporation. Service: 04/30/2021 by email. [772402] --[Edited 05/04/2021 by KMH - compliance review complete] [Francis Cerrito] [Entered: 04/30/2021 08:57 PM] (42)
Apr 30, 2021 33 Notice from Appellees Mylan Inc., Mylan N.V. and Mylan Pharmaceuticals Inc. Withdrawal of Adam W. Burrowbridge as Counsel. Service: 04/30/2021 by email. [772394] [21-1154] [Steffen Johnson] [Entered: 04/30/2021 06:17 PM] (2)
Apr 30, 2021 32 NOTICE OF NON-COMPLIANCE: The submission of Appellant Celgene Corporation, Non-Confidential Reply Brief [28], is not in compliance with the rules of this court (see attached). Compliant document due on 05/07/2021. Unless ordered otherwise, the deadline for any responsive filing runs from service of the original version. Service as of this date by the Clerk of Court. [772285] [KMH] [Entered: 04/30/2021 10:23 AM] (2)
Apr 26, 2021 31 Joint Statement of Compliance with Fed. Cir. R. 33 for Appellant Celgene Corporation and Appellees Mylan Inc., Mylan N.V. and Mylan Pharmaceuticals Inc.. Service: 04/26/2021 by email. [771277] [21-1154] [Francis Cerrito] [Entered: 04/26/2021 05:21 PM] (3)
Apr 26, 2021 30 MODIFIED ENTRY: CONFIDENTIAL APPENDIX FILED by Appellant Celgene Corporation and Appellees Mylan Inc., Mylan N.V. and Mylan Pharmaceuticals Inc.. Service: 04/26/2021 by email. [771268]--[Edited 05/04/2021 by KMH - compliance review complete] [Francis Cerrito] [Entered: 04/26/2021 04:27 PM] (0)
Apr 26, 2021 29 MODIFIED ENTRY: APPENDIX FILED by Appellant Celgene Corporation and Appellees Mylan Inc., Mylan N.V. and Mylan Pharmaceuticals Inc.. Service: 04/26/2021 by email. [771265] --[Edited 05/04/2021 by KMH - compliance review complete] [Francis Cerrito] [Entered: 04/26/2021 04:23 PM] (580)
Apr 19, 2021 27 MODIFIED ENTRY: CONFIDENTIAL REPLY BRIEF FILED by Appellant Celgene Corporation. Service: 04/19/2021 by email. [769762]--[Edited 04/30/2021 by KMH - compliance review complete] [Francis Cerrito] [Entered: 04/19/2021 09:12 PM] (0)
Apr 19, 2021 28 REPLY BRIEF FILED by Appellant Celgene Corporation. Service: 04/19/2021 by email. [769764] [21-1154] This document is non-compliant. See Doc No. [32] [Francis Cerrito] [Entered: 04/19/2021 09:13 PM] (42)
Mar 26, 2021 26 **TEXT ONLY** ORDER granting motion to extend time to file brief [25] filed by Appellant Celgene Corporation. The reply brief is due 04/19/2021. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [764935] [KMH] [Entered: 03/26/2021 10:45 AM] (0)
Mar 24, 2021 25 MOTION of Appellant Celgene Corporation to extend the time to 04/19/2021 to file brief. Service: 03/24/2021 by email. [764537] [21-1154] [Francis Cerrito] [Entered: 03/24/2021 03:07 PM] (8)
Mar 15, 2021 24 Amended Certificate of Interest for Appellees Mylan Inc., Mylan N.V. and Mylan Pharmaceuticals Inc.. Service: 03/15/2021 by email. [762544] [21-1154] [Steffen Johnson] [Entered: 03/15/2021 11:54 PM] (3)
Mar 15, 2021 23 MODIFIED ENTRY: RESPONSE BRIEF FILED by Appellees Mylan Inc., Mylan N.V. and Mylan Pharmaceuticals Inc.. Service: 03/15/2021 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [762541] --[Edited 03/18/2021 by KMH - compliance review complete] [Steffen Johnson] [Entered: 03/15/2021 11:29 PM] (72)
Mar 15, 2021 22 MODIFIED ENTRY: CONFIDENTIAL RESPONSE BRIEF FILED by Appellees Mylan Inc., Mylan N.V. and Mylan Pharmaceuticals Inc.. Service: 03/15/2021 by email. [762540]--[Edited 03/18/2021 by KMH - compliance review complete] [Steffen Johnson] [Entered: 03/15/2021 11:26 PM] (0)
Mar 15, 2021 21 Entry of appearance for G. Edward Powell III as counsel for Appellees Mylan Inc., Mylan N.V. and Mylan Pharmaceuticals Inc.. Service: 03/15/2021 by email. [762539] [21-1154] [George Powell] [Entered: 03/15/2021 11:22 PM] (1)
Feb 18, 2021 20 Entry of appearance for Steffen N. Johnson; Adam Burrowbridge as counsel for Appellees Mylan Inc., Mylan N.V. and Mylan Pharmaceuticals Inc.. Service: 02/18/2021 by email. [757069] [21-1154] [Steffen Johnson] [Entered: 02/18/2021 02:47 PM] (2)
Feb 12, 2021 19 MODIFIED ENTRY: CORRECTED BRIEF FILED by Appellant Celgene Corporation. Service: 02/12/2021 by email. [756005] --[Edited 02/17/2021 by KMH - compliance review complete] [Francis Cerrito] [Entered: 02/12/2021 09:20 PM] (128)
Feb 12, 2021 18 MODIFIED ENTRY: CORRECTED CONFIDENTIAL BRIEF FILED by Appellant Celgene Corporation. Service: 02/12/2021 by email. [756004]--[Edited 02/17/2021 by KMH - compliance review complete] [Francis Cerrito] [Entered: 02/12/2021 09:18 PM] (0)
Feb 12, 2021 17 NOTICE OF NON-COMPLIANCE: The submission of Appellant Celgene Corporation, Opening Brief [10], [12], is not in compliance with the rules of this court (see attached). Compliant documents due on 02/18/2021. Unless ordered otherwise, the deadline for any responsive filing runs from service of the original version. Service as of this date by the Clerk of Court. [755809] [KMH] [Entered: 02/12/2021 12:37 PM] (2)
Feb 11, 2021 16 ORDER denying as moot [11] the appellant's motion to waive the requirements of Federal Circuit Rule 25.1(d)(1), ECF No. 11, and the appellees' motion to hold that in abeyance, [13] ECF No. 13. The appellant is directed to file a corrected confidential opening brief and corrected non-confidential opening brief within 7 days of the date of filing of this order. The appellees' unopposed motion, [14] ECF No. 14, to extend the time to file their response brief up to and including March 15, 2021 is granted. Service as of this date by the Clerk of Court. [755299] [LMS] [Entered: 02/11/2021 08:18 AM] (2)
Feb 8, 2021 15 Letter from Appellees Mylan Inc., Mylan N.V. and Mylan Pharmaceuticals Inc. Update on Celgene's Motion to Exceed Confidential Marking Limitations. Service: 02/08/2021 by email. [754656] [21-1154] [Tung Kong] [Entered: 02/08/2021 07:19 PM] (1)
Feb 8, 2021 14 MOTION of Appellees Mylan Inc., Mylan N.V. and Mylan Pharmaceuticals Inc. to extend the time to 03/15/2021 to file brief. Service: 02/08/2021 by email. [754493] [21-1154] [Tung Kong] [Entered: 02/08/2021 01:08 PM] (9)
Jan 22, 2021 13 RESPONSE of Appellees Mylan Inc., Mylan N.V. and Mylan Pharmaceuticals Inc. to the motion to waive confidentiality requirements [11] filed by Appellant Celgene Corporation with MOTION to Hold Motion in Abeyance. Service: 01/01/2021 by email [751323] [21-1154] [Tung Kong] [Entered: 01/22/2021 09:45 PM] (10)
Jan 19, 2021 12 OPENING BRIEF FILED by Appellant Celgene Corporation. Service: 01/19/2021 by email. [750324] [21-1154] This document is non-compliant. See Doc No. [17] [Francis Cerrito] [Entered: 01/19/2021 11:42 PM] (128)
Jan 19, 2021 11 MOTION of Appellant Celgene Corporation to waive confidentiality requirements. Service: 01/19/2021 by email. [750322] [21-1154] [Francis Cerrito] [Entered: 01/19/2021 11:40 PM] (10)
Jan 19, 2021 10 CONFIDENTIAL OPENING BRIEF FILED by Appellant Celgene Corporation. Service: 01/19/2021 by email. [750321] [21-1154] This document is non-compliant. See Doc No. [17] [Francis Cerrito] [Entered: 01/19/2021 11:37 PM] (0)
Dec 23, 2020 9 **TEXT ONLY** ORDER granting motion to extend time to file brief [8] filed by Appellant Celgene Corporation. The opening brief is due 01/19/2021. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [744987] [EKD] [Entered: 12/23/2020 09:47 AM] (0)
Dec 18, 2020 8 MOTION of Appellant Celgene Corporation to extend the time to 01/19/2021 to file brief. Service: 12/18/2020 by email. [743795] [21-1154] [Francis Cerrito] [Entered: 12/18/2020 12:45 PM] (8)
Nov 19, 2020 7 Docketing Statement for the Appellees Mylan Inc., Mylan N.V. and Mylan Pharmaceuticals Inc.. Service: 11/19/2020 by email. [737121] [21-1154] [Tung Kong] [Entered: 11/19/2020 07:39 PM] (2)
Nov 19, 2020 6 Certificate of Interest for Appellees Mylan Inc., Mylan N.V. and Mylan Pharmaceuticals Inc.. Service: 11/19/2020 by email. [737120] [21-1154] [Tung Kong] [Entered: 11/19/2020 07:38 PM] (3)
Nov 19, 2020 5 Entry of appearance for Tung-On Kong; Elham F. Steiner; Kristina M. Hanson as counsel for Appellees Mylan Inc., Mylan N.V. and Mylan Pharmaceuticals Inc.. Service: 11/19/2020 by email. [737119] [21-1154] [Tung Kong] [Entered: 11/19/2020 07:36 PM] (2)
Nov 19, 2020 4 Docketing Statement for the Appellant Celgene Corporation. Service: 11/19/2020 by email. [737100] [21-1154] [Eric Stops] [Entered: 11/19/2020 06:11 PM] (2)
Nov 19, 2020 3 Certificate of Interest for Appellant Celgene Corporation. Service: 11/19/2020 by email. [737099] [21-1154] [Eric Stops] [Entered: 11/19/2020 06:09 PM] (4)
Nov 19, 2020 2 Entry of appearance for F. Dominic Cerrito; Eric C. Stops; Frank C. Calvosa; Ellyde R. Thompson; Jennifer L. Swize; Matthew J. Hertko as counsel for Appellant Celgene Corporation. Service: 11/19/2020 by email. [737098] [21-1154] [Eric Stops] [Entered: 11/19/2020 06:08 PM] (2)
Nov 5, 2020 1 Appeal docketed. Received: 10/29/2020. [733958]Entry of Appearance is due 11/19/2020. Certificate of Interest is due 11/19/2020. Docketing Statement is due 11/19/2020. Appellant's brief is due 01/04/2021. [KMH] [Entered: 11/05/2020 01:57 PM] (39)
Menu